Levy M, Cernacek P
Department of Physiology, McGill University, Montreal, Canada.
Kidney Int. 1993 Jun;43(6):1236-42. doi: 10.1038/ki.1993.175.
Atrial natriuretic peptide (ANP) is thought to exert its major effect within the cortical and inner medullary collecting ducts (CCD and IMCD) by inhibiting Na+ transport along conductive channels and electroneutral pathways. These transport routes are also thought to be inhibited by a combination of amiloride, thiazide and bradykinin. We tested the ability of normal dogs to respond to ANP when various combinations of these Na+ transport inhibitors were present. In 24 dogs ANP raised UNaV from 31 +/- 6 to 223 +/- 41 mu Eq/min (P < 0.05), a delta of 192 mu Eq/min. Bradykinin alone did not depress delta UNaV in response to an ANP infusion. In the presence of extreme natriuresis caused by amiloride and thiazide, the response to ANP was magnified, presumably due to augmented Na+ delivery to the CCD and IMCD. When distal delivery of Na+ to one kidney was controlled by aortic clamping in the presence of amiloride, thiazide and bradykinin. delta UNaV in response to ANP was depressed (48 vs. 168 mu Eq/min). We conclude that in the presence of extreme inhibition of Na+ transport within the collecting ducts, ANP can still cause a further natriuresis, probably in the absence of augmented distal Na+ delivery.
心房利钠肽(ANP)被认为主要通过抑制沿传导通道和电中性途径的Na+转运,从而在皮质和髓质内集合管(CCD和IMCD)发挥作用。这些转运途径也被认为会受到氨氯地平、噻嗪类和缓激肽联合作用的抑制。我们测试了在存在这些Na+转运抑制剂的各种组合时,正常犬对ANP的反应能力。在24只犬中,ANP使尿钠排泄率(UNaV)从31±6增加到223±41μEq/min(P<0.05),增量为192μEq/min。单独使用缓激肽不会降低对ANP输注的尿钠排泄率增量。在氨氯地平和噻嗪类引起的极度利钠情况下,对ANP的反应增强,推测是由于向CCD和IMCD的Na+输送增加。当在氨氯地平、噻嗪类和缓激肽存在的情况下,通过主动脉夹闭控制Na+向一侧肾脏的远端输送时,对ANP的尿钠排泄率增量降低(48对168μEq/min)。我们得出结论,在集合管内Na+转运受到极度抑制的情况下,ANP仍可导致进一步的利钠作用,可能是在远端Na+输送未增加的情况下。